- Home
- UCTT vs HUMAW Comparison
UCTT vs HUMAW Comparison
Compare UCTT & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- HUMAW
- Stock Information
- Founded
- UCTT 1991
- HUMAW N/A
- Country
- UCTT United States
- HUMAW United States
- Employees
- UCTT N/A
- HUMAW 185
- Industry
- UCTT Semiconductors
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- HUMAW Health Care
- Exchange
- UCTT Nasdaq
- HUMAW Nasdaq
- Market Cap
- UCTT N/A
- HUMAW N/A
- IPO Year
- UCTT 2004
- HUMAW 2020
- Fundamental
- Price
- UCTT $32.94
- HUMAW $1.60
- Analyst Decision
- UCTT Strong Buy
- HUMAW
- Analyst Count
- UCTT 3
- HUMAW 0
- Target Price
- UCTT $58.67
- HUMAW N/A
- AVG Volume (30 Days)
- UCTT 349.8K
- HUMAW N/A
- Earning Date
- UCTT 10-23-2024
- HUMAW N/A
- Dividend Yield
- UCTT N/A
- HUMAW N/A
- EPS Growth
- UCTT N/A
- HUMAW N/A
- EPS
- UCTT N/A
- HUMAW N/A
- Revenue
- UCTT $1,873,600,000.00
- HUMAW N/A
- Revenue This Year
- UCTT $19.86
- HUMAW N/A
- Revenue Next Year
- UCTT $16.74
- HUMAW N/A
- P/E Ratio
- UCTT N/A
- HUMAW N/A
- Revenue Growth
- UCTT N/A
- HUMAW N/A
- 52 Week Low
- UCTT $22.15
- HUMAW N/A
- 52 Week High
- UCTT $56.47
- HUMAW N/A
- Technical
- Relative Strength Index (RSI)
- UCTT 29.39
- HUMAW N/A
- Support Level
- UCTT $36.51
- HUMAW N/A
- Resistance Level
- UCTT $38.25
- HUMAW N/A
- Average True Range (ATR)
- UCTT 1.40
- HUMAW 0.00
- MACD
- UCTT -0.13
- HUMAW 0.00
- Stochastic Oscillator
- UCTT 2.70
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.